Results of a randomized study of Bexxar (TM) (tositumomab and iodine I 131 tositumomab) vs. unlabeled tositumomab in patients with relapsed or refractory low-grade or transformed non-Hodgkin's lymphoma (NHL) Meeting Abstract
| Authors: | Davis, T. A.; Kaminski, M. S.; Leonard, J. P.; Gregory, S. A.; Wahl, R.; Hsu, F. J.; Wilkinson, M.; Frankel, S. R.; Serafini, A.; Zelenetz, A. D.; Kroll, S.; Coleman, M.; Levy, R.; Knox, S. J. |
| Abstract Title: | Results of a randomized study of Bexxar (TM) (tositumomab and iodine I 131 tositumomab) vs. unlabeled tositumomab in patients with relapsed or refractory low-grade or transformed non-Hodgkin's lymphoma (NHL) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 98 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2001 Dec 7-11 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2001-11-16 |
| Start Page: | 843a |
| Language: | English |
| ACCESSION: | WOS:000172134103516 |
| PROVIDER: | wos |
| PUBMED: | 11727739 |
| Notes: | Meeting Abstract: 3503 -- Source: Wos |
